NEW YORK — Trabectome surgery is a reasonable approach in patients with mild glaucoma, a speaker said here. "We would recommend it for patients with high preoperative IOP or a target IOP of more than ...

Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near tasks than those with monofocal ...

The analysis published in Clinical Ophthalmology suggests that OMNI was as effective at lowering IOP and reducing medication usage in advanced glaucoma as it was in mild and moderate glaucoma. MENLO ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...

May 3, 2012 (Chicago, Illinois) — The second-generation GTS400 stent has a high intraoperative reliability, and appears to be safe and effective, with a postoperative decrease in intraocular pressure ...

More than half of people getting a certain type of glaucoma surgery may suffer from temporary, sometimes severe vision loss afterwards, suggests a new study. A smaller proportion, about 8 in every 100 ...

Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...

MENLO PARK, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address ...